BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23539444)

  • 61. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
    Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
    J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of a second Arabidopsis thaliana prolyl 4-hydroxylase with distinct substrate specificity.
    Tiainen P; Myllyharju J; Koivunen P
    J Biol Chem; 2005 Jan; 280(2):1142-8. PubMed ID: 15528200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha.
    Baek JH; Mahon PC; Oh J; Kelly B; Krishnamachary B; Pearson M; Chan DA; Giaccia AJ; Semenza GL
    Mol Cell; 2005 Feb; 17(4):503-12. PubMed ID: 15721254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point.
    Khanna S; Roy S; Maurer M; Ratan RR; Sen CK
    Free Radic Biol Med; 2006 Jun; 40(12):2147-54. PubMed ID: 16785028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
    Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
    Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
    Huang M; Nguyen P; Jia F; Hu S; Gong Y; de Almeida PE; Wang L; Nag D; Kay MA; Giaccia AJ; Robbins RC; Wu JC
    Circulation; 2011 Sep; 124(11 Suppl):S46-54. PubMed ID: 21911818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of collagen type specificity for lysyl hydroxylase isoforms.
    Wang C; Valtavaara M; Myllylä R
    DNA Cell Biol; 2000 Feb; 19(2):71-7. PubMed ID: 10701773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces haem oxygenase-1 expression in human cells through a mechanism independent of hypoxia-inducible factor-1alpha.
    Li B; Takeda K; Yokoyama S; Shibahara S
    J Biochem; 2008 Nov; 144(5):643-54. PubMed ID: 18799519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha.
    Koivunen P; Tiainen P; Hyvärinen J; Williams KE; Sormunen R; Klaus SJ; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Oct; 282(42):30544-52. PubMed ID: 17726031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
    Huang KT; Mikeska T; Dobrovic A; Fox SB
    Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Zhang J; Guo S; Wu Y; Zheng ZC; Wang Y; Zhao Y
    Biomed Res Int; 2019; 2019():9749751. PubMed ID: 31467922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prolyl hydroxylases and therapeutics.
    Smith TG; Talbot NP
    Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prolyl hydroxylase inhibitor and lysyl hydroxylase inhibitor inhibit spreading of corneal epithelium.
    Saika S; Hashizume N; Okada Y; Kobata S; Yamanaka O; Uenoyama K; Ooshima A
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):499-502. PubMed ID: 7926886
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
    Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hydralazine differentially increases mRNAs for the alpha and beta subunits of prolyl 4-hydroxylase whereas it decreases pro alpha 1(I) collagen mRNAs in human skin fibroblasts.
    Yeowell HN; Murad S; Pinnell SR
    Arch Biochem Biophys; 1991 Sep; 289(2):399-404. PubMed ID: 1654861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate.
    Majamaa K; Turpeenniemi-Hujanen TM; Latipää P; Günzler V; Hanauske-Abel HM; Hassinen IE; Kivirikko KI
    Biochem J; 1985 Jul; 229(1):127-33. PubMed ID: 2994628
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues.
    Vranka J; Stadler HS; Bächinger HP
    Cell Struct Funct; 2009; 34(2):97-104. PubMed ID: 19652424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
    Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
    Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.